EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells

Ji-Sun Lee, Ho-Young Lee

Journal of Ginseng Research · 2024-05 · 48 (3) · 266-275

DOI: 10.1016/j.jgr.2024.03.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Ginseng Research, 2024-05. Verfasst von Ji-Sun Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cell & Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) are a rare subpopulation of cancer cells that exhibit stem cell-like characteristics, including self-renewal and differentiation in a multi-stage lineage state via symmetric or asymmetric division, causing tumor initiation, heterogeneity, progression, and recurrence and posing a major challenge to current anticancer therapy. Despite the importance of CSCs in carcinogenesis and cancer progression, currently available anticancer therapeutics have limitations for eradicating CSCs. Moreover, the efficacy and therapeutic windows of currently available anti-CSC agents are limited, suggesting the necessity to optimize and develop a novel anticancer agent targeting CSCs. Ginseng has been traditionally used for enhancing immunity and relieving fatigue. As ginseng's long history of use has demonstrated its safety, it has gained attention for its potential pharmacological properties, including anticancer effects. Several studies have identified the bioactive principles of ginseng, such as ginseng saponin (ginsenosides) and non-saponin compounds (e.g., polysaccharides, polyacetylenes, and phenolic compounds), and their pharmacological activities, including antioxidant, anticancer, antidiabetic, antifatigue, and neuroprotective effects. Notably, recent reports have shown the potential of ginseng-derived compounds as anti-CSC agents. This review investigates the biology of CSCs and efforts to utilize ginseng-derived components for cancer treatment targeting CSCs, highlighting their role in overcoming current therapeutic limitations.

Schlagwörter

Stichwörter der Autor:innen

Cancer stem cellsGinseng-derived compoundsGinsenosidesNon-saponinPanax ginseng

Autor:innen und Institutionen

  • Department of Molecular, Cell & Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Lee, J. S., & Lee, H. Y. (2024). Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells. Journal of Ginseng Research, 48(3), 266-275. https://doi.org/10.1016/j.jgr.2024.03.003

Vancouver

Lee JS, Lee HY. Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells. Journal of Ginseng Research. 2024;48(3):266-275. doi:10.1016/j.jgr.2024.03.003

BibTeX
@article{Lee2024,
  author = {Lee, Ji-Sun and Lee, Ho-Young},
  title = {Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells},
  journal = {Journal of Ginseng Research},
  year = {2024},
  volume = {48},
  number = {3},
  pages = {266--275},
  doi = {10.1016/j.jgr.2024.03.003}
}
Kostenlos starten →